25-09-2026 17:24 via drugs.com

U.S. Study Shows Blood-Based Multicancer Early Detection Test Can ID Cancer Signals

FRIDAY, Sept. 25, 2026-- A blood-based multicancer early detection (MCED) test that predicts cancer signal origin (CSO) has a positive predictive value of 60.3 percent for participants aged 50 years or older without clinical suspicion of cancer...

PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy

Steatotic Liver Disease Risk Scores Compared for Predicting Cirrhosis

Reducing Ultraprocessed Food May Alleviate Symptoms of Depression

UACR, UPCR Provide Indistinguishable Prognostic Information in CKD

Loneliness, Isolation Can Strip Away Years Of Healthy Life, Large Study Finds

Stroke Rates Nearly Double In Younger Adults

How The MIND Diet Protects Aging Brains

Keeping A Steady Job Might Help You Stay Sharp Later In Life

Depressed? Try Cutting Back On Ultra-Processed Foods, Study Suggests

As Health Insurance Costs Soar, Healthcare Workers Also Feel The Pinch

Age-Adjusted Suicide Rate Increased From 2014 to 2017 and Then Plateaued

IBD Not Linked to Risk for Hypertensive Disorders of Pregnancy Overall

Multicomponent Interventions Offer Little Impact on Fall Risk

Sugar Exposure in Early Life Linked to Anxiety in Adulthood

Desktop versie

U.S. Study Shows Blood-Based Multicancer Early Detection Test Can ID Cancer Signals

Pharmaceutical news